Industry

Drug recall: Bharat Biotech voluntarily recalls ChiroRaba vaccine due to this reason

This action was initiated due to the theft of Chirorabâ from the shipping services provider in Karnataka, a company statement notified today.

The Health Master

January 26, 2023

212

Last Updated on October 15, 2024 by The Health Master

Bharat Biotech has issued a voluntary drug recall of a specific batch of Chirorabâ vaccine with batch No. 4188.

This action was initiated due to the theft of Chirorabâ from the shipping services provider in Karnataka, a company statement notified today.

Click for more articles on Drugs recall

The statement noted that in accordance with company and regulatory requirements, batch No. 4188 was fully tested and released.

While only part of the shipment was stolen, for which cold chain storage conditions are unknown, the action to recall the entire batch has been initiated.

“The company requests that batch No. 4188 not be sold and returned to the company. Healthcare providers are requested not to administer Chirorabâ with batch No. 4188.”

“We are undertaking this voluntary action in accordance with the Principle of Abundant Precaution, keeping patient safety and the public interest in mind,” the statement concluded.

Other drugs recall

Drug recall: Rifampin Capsules recalled due to this reason

Drug recall: Epinephrine API recalled due to this reason

Drug recall: Daptomycin for Injection recalled due to this reason

Drug recall: Vancomycin Hydrochloride Injection recalled due to this reason

Drug recall: 4 lots of Quinapril Tablets recalled due to this reason

Drug recall: This Blood Pressure tablets recalled

Also read

PCI should add vaccination subject in pharmacy syllabus

USFDA issues Form 483 with 9 observations to Indoco Remedies, Goa

Medical device: Industry seeks clarity on misbranded and adulterated devices

High BP drugs could be repurposed to delay ageing: Research